Therapy of neurotic and pseudoneurotic symptoms with tofisopam
Libus, J.; Libusova, E.
Agressologie Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 22(D): 21-22
1981
ISSN/ISBN: 0002-1148 PMID: 6120662 Document Number: 169718
Document emailed within 1 workday
Related Documents
Lakosina, N.D. 1974: The prognostic value of initial disorders in neurotic and pseudoneurotic states Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 74(11): 1688-1692Danes, L.; Raboch, J.; Sonka, J.; Raboch, J. 1990: Neurotic symptoms in obese women Casopis Lekaru Ceskych 129(20): 619-621
Aleksandrowicz, J.W. 2001: Changes in the recurrence rate of neurotic symptoms Psychiatria Polska 35(3): 351-377
Ekiert, H.; Gogol, Z.; Welbel, L.; Buchowska, I. 1973: Electroclinical aspect of insidon treatment in patients with neurotic symptoms Psychiatria Polska 7(2): 169-177
Skovronsky, O.; boleloucky, Z.; Bastecky, J. 1981: Anxiety and other neurotic symptoms in patients suffering from dans la conception des états limitrophes et des mécanismes d'action clinique des tranquillisants Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 22(C): 25-26
Godbey, A.L.; Guerra, J.R. 1970: Pseudoneurotic schizophrenia Journal of the Florida Medical Association 57(4): 17-21
Sladká, R.; Dostálová, J.; Haskovcová, V.; Jarosová, M.; Slánská, J.; Faltus, F.; Filip, V. 1978: Placebo controlled study with tofisopam in anxious neurosis Activitas Nervosa Superior 20(4): 245-246
Tóth, M.ár.; Bajnógel, J.; Egyed, A.ás.; Drabant, S.án.; Tömlo, J.; Klebovich, I. 2005: Effect of tofisopam on CYP3A4 enzyme activity on human recombinant 3A4 supersome Acta Pharmaceutica Hungarica 75(4): 195-198
Folstein, M.; Folstein, S.; McHugh, P.R. 1973: Clinical predictors of improvement after electroconvulsive therapy of patients with schizophrenia, neurotic reactions, and affective disorders Biological Psychiatry 7(2): 147-152
Garganeeva, N.P.; Kartashova, I.G.; Semke, V.I. 2009: Peptic ulcer in patients with neurotic and affective disorders: comorbidity, clinicoendoscopic and psychopathological features, approaches to therapy Terapevticheskii Arkhiv 81(11): 44-48
Leschke, M.; Mecklenbeck, W.; Strauer, B.E. 1992: Chronic intermittent urokinase therapy in inoperable end-stage coronary disease with therapy refractory angina pectoris symptoms Medizinische Klinik 87(7): 385-389
Ylieff, M. 1977: Behavior therapy and neurotic behavior Acta Psychiatrica Belgica 77(1): 45-83
Stern, S.L.; Mendels, J. 1980: Withdrawal symptoms during the course of imipramine therapy Journal of Clinical Psychiatry 41(2): 66-67
Classen, H.-G.; Gröber, U.; Löw, D.; Schmidt, J.; Stracke, H. 2011: Zinc deficiency. Symptoms, causes, diagnosis and therapy Medizinische Monatsschrift für Pharmazeuten 34(3): 87-95
Kohn, R.; Mot'ovská, Z. 1997: Mushroom poisoning--classification, symptoms and therapy Vnitrni Lekarstvi 43(4): 230-233
Cullberg, J. 1980: Estrogen therapy in psychiatric symptoms associated with climacteric Lakartidningen 77(9): 785-787
Kalinowska, S.; Nitsch, K.; Duda, P.; Trześniowska-Drukała, B.; Samochowiec, J. 2013: Depression in children and adolescents -symptoms, etiology, therapy Annales Academiae Medicae Stetinensis 59(1): 32-36
Szkutnik-Fiedler, D.; Jedrzejczyk, M.łg.; Grześkowiak, E.; Bartkowiak-Wieczorek, J.; Seremak-Mrozikiewicz, A.; Drews, K.; Mrozikiewicz, P.ła.M. 2010: The role of phytoestrogen therapy in relieving postmenopausal symptoms Ginekologia Polska 81(12): 929-934
Von Arx-Strässler, F. 2011: Trembling awakening - withdrawal symptoms after pain therapy Kinderkrankenschwester: Organ der Sektion Kinderkrankenpflege 30(6): 240-241
Gero, L.ás.ó 2004: Pathogenesis, symptoms and therapy of type-1 diabetes mellitus Orvosi Hetilap 145(46): 2339-2343